Similar Articles |
|
IndustryWeek January 1, 2008 Nick Zubko |
Regaining Cost-Consciousness The A&D industry wakes up to new ways to reduce procurement costs. |
IndustryWeek February 1, 2007 Traci Purdum |
Aligning Business Functions Pays Off Recent study outlines best practices to ensure a world-class procurement function. |
IndustryWeek March 1, 2007 Traci Purdum |
Outsourcing Procurement Personal-paper-products maker Kimberly-Clark aims to focus on what it does best. |
The Motley Fool December 14, 2004 Brian Gorman |
Bristol-Myers' Smart Moves Although problems still hang over the company, Bristol-Myers is paving the way for recovery. In the meantime investors will surely be jittery. |
IndustryWeek March 1, 2007 Traci Purdum |
Indirect Procurement Gets The Shaft Companies choose to outsource function to improve service. |
The Motley Fool July 10, 2007 Brian Orelli |
Sometimes, the Same Is Good Enough Bristol-Myers Squibb's new drug doesn't work better, but it's easier to take. Investors, take note. |
IndustryWeek November 1, 2008 Nick Zubko |
Eager for E-procurement Factors fueling new software adoption continue to focus on procurement's core goals. |
IndustryWeek February 1, 2008 Nick Zubko |
Cost in Translation More effective sourcing efforts could be as simple as getting your procurement and finance departments to speak the same language. |
IndustryWeek December 1, 2008 Nick Zubko |
The Talent Search New skills and capabilities will be in high demand as procurement moves away from traditional responsibilities. |
FAO Today Mar/Apr 2008 Lisa Ross |
Department Procurement: Try Adding Procurement By outsourcing finance & accounting and procurement together, you can fan the flames of powerful synergies that will go straight to the bottom line -- while helping to improve operations. |
HRO Today Jul/Aug 2008 Atul Vashistha |
Is Global Sourcing an Item on Your Strategic Plan of Action? Survey examines what buyers are thinking when it comes to sourcing services on a global scale. |
IndustryWeek April 15, 2009 Josh Cable |
Creating 'Interlock' Five strategies to keep the relationship between procurement and R&D in gear. |
The Motley Fool December 26, 2007 Brian Lawler |
Exelixis Awaits Bristol-Myers Decision Even if Bristol-Myers Squibb decides to discontinue their partnership, it might not mean the end of the road for Exelixis' cancer treatment. |
The Motley Fool August 1, 2008 Brian Lawler |
Is $60 a Share Enough for ImClone? Bristol-Myers Squibb announced a $60-per-share offer for ImClone Systems, but are shareholders going to go for the deal? |
The Motley Fool January 28, 2009 Brian Orelli |
A Mini-Pfizer in the Making Bristol-Myers Squibb looks like its setting itself up to be the next Pfizer. |
IndustryWeek October 1, 2006 John Teresko |
The Services Procurement Challenge Outside and indirect services spending averages 15% of revenue. |
IndustryWeek May 16, 2012 David Blanchard |
Straight Talk about Indirect Procurement The finance and purchasing departments need to get on the same page about their indirect procurement. |
IndustryWeek April 1, 2002 Jill Jusko |
Procurement -- Not All Dollars And Cents Despite the downswing in the economy, manufacturers continue to strive for collaborative procurement partnerships... |
Pharmaceutical Executive February 1, 2011 Frederic Brunner |
Growing Stronger After the Storm To manage through a resource-constrained environment, it is essential to get the most out of procurement planning |
InternetNews March 10, 2009 Alex Goldman |
Oracle Sourcing Goes SaaS Oracle continues its adoption of the on-demand model. |
IndustryWeek April 1, 2008 Nick Zubko |
Speaking Out on Outsourcing Study shows more companies are now willing to outsource procurement tasks. |
FAO Today Nov/Dec 2007 Peggy Cope |
The Drive to Procurement Outsourcing ICG Commerce CEO talks about the drivers, challenges, and best practices of outsourcing your procurement. |
The Motley Fool April 28, 2008 Brian Lawler |
Bristol-Myers' Comeback Continues The pharmaceutical's first quarter brings more robust results. |
The Motley Fool April 27, 2006 Stephen D. Simpson |
A Sluggish Bristol-Myers Squibb Generic erosion is going to chew away revenue and profits. Investors, at today's prices, there are just too many other better ideas to go after. |
The Motley Fool September 22, 2008 Brian Lawler |
Why Bristol-Myers Won't Pull Its ImClone Bid Bristol-Myers might drop its cash bid of $60 per share to acquire longtime partner ImClone Systems. |
The Motley Fool April 7, 2009 Brian Orelli |
Bristol-Myers Squibb: On the Patent Cliff's Edge Bristol-Myers Squibb changed its huge patent cliff into two smaller falls with a larger ledge in the middle. |
CFO May 15, 2012 Josh Hyatt |
The Rise and Rise of Procurement Like CFOs of yore, procurement executives are shedding their roles as stewards and becoming what their companies need them to be: strategic thinkers. |
IndustryWeek December 1, 2008 Nick Zubko |
Matters of Perception Many procurement teams feel underused and under-appreciated, but now could be their chance to shine. |
U.S. Banker August 2010 Podrebarac & Ortiz |
Getting Back to Growth by Managing Costs Banks must pull costs out of areas that are not central to their mission and put the savings into capabilities that customers care about. |
Bank Systems & Technology February 21, 2008 Maria Bruno-Britz |
Comerica Awards BPO Contract to Accenture Accenture will provide COmerica with outsourced management of its procurement operations. |
The Motley Fool December 12, 2008 Brian Orelli |
An EXELent Drug Deal Exelixis picks up $195 million in cash in a licensing deal with Bristol-Myers Squibb. |
National Real Estate Investor October 1, 2002 Larry Hall |
Finding the Holes in Purchasing Policies The growth of real estate portfolios triggered many inefficiencies that are now apparent in a down economy. Despite greater scrutiny of spending, many real estate executives remain unaware of the high price of wasteful procurement operations. |
The Motley Fool October 30, 2006 Brian Lawler |
Sales Slow Down for Bristol-Myers Plavix isn't the only drug facing a challenging future. Losing patent protection and facing generic competition can be disastrous to sales and earnings if a pharmaceutical company doesn't have a way to drive revenue growth. Investors, take note. |
Global Services June 27, 2007 |
The Global Sourcers More and more people are sourcing services from around the world for their companies. But do they have the right skills for a job that is becoming increasingly strategic to their companies? |
The Motley Fool May 1, 2007 Brian Lawler |
Bristol-Myers Stops Spinning in Place Bristol-Myers releases first-quarter financial results. Investors, take note. |
FAO Today Nov/Dec 2007 Rachael Stormonth |
Are Vendors Contributing To the Slowdown in New Procurement BPO? Mismatches between buy-side requirements and vendors' services and capabilities prove challenging. |
The Motley Fool March 30, 2009 Brian Orelli |
Here's Some Cash. Go Away. Bristol-Myers Squibb has to pay $2.1 million to settle a Federal Trade Commission investigation. |
The Motley Fool February 28, 2007 Brian Lawler |
Bristol-Myers Stays Out of Trouble A federal monitor finds Bristol-Myers does not have to pay up over a questionable business deal. |
The Motley Fool September 20, 2004 Wherrett & Yelovich |
Flamel Shot Down The company's nano product loses some of its shine. The stock fell more than 25% after Bristol-Myers Squibb pulled out of its partnership to develop Basulin. |
IndustryWeek July 1, 2008 Nick Zubko |
First-Hand Accounts: By The Numbers Electronic connectivity with suppliers improves cost savings in procurement and accounts payable, study says. |
IndustryWeek November 17, 2010 |
Trimming the Fat From Indirect Procurement Industrial manufacturers are looking to sharply reduce transactional costs and the number of purchase orders. |
The Motley Fool July 29, 2004 Brian Gorman |
Bristol-Myers Bottoming Out? The pharmaceutical company's expectations are in doubt, but investors might want to focus on its potential. |
IndustryWeek September 14, 2011 |
Time To Tell Your CPOs to Collaborate With Suppliers How to create value by collaborating inside and outside the organization. |
The Motley Fool April 29, 2009 Brian Orelli |
Parachutes, Cliffs, and Softer Landings Bristol-Myers Squibb faces a major patent cliff in a few years, and it's doing everything it can to make the fall as painless as possible. Early indications from yesterday's first-quarter earnings report look promising. |
The Motley Fool December 31, 2007 Rick Aristotle Munarriz |
4 Stocks That Took a Hike These companies recently raised their dividends: Bristol-Myers Squibb... Freeport McMoRan... Kayne Anderson... Commercial Metals... |
The Motley Fool October 28, 2005 Stephen D. Simpson |
Bristol-Myers' Bad Mojo The possible loss of the experimental diabetes drug Pargluva is a blow to this pharmaceutical that's already hurting for growth. If you're expecting a near-term bang for your investment buck, this might not be the best destination. |
IndustryWeek July 22, 2009 Steve Minter |
Risky Disconnect Between Purchasing and Finance Only 28% of CFOS said they believe procurement has a significant impact on financial risk exposure. |
The Motley Fool January 27, 2005 Stephen D. Simpson |
Generics Bout Gets Bloody Bristol-Myers Squibb struggles to keep growing amid patent expirations. |
The Motley Fool November 17, 2009 Brian Orelli |
Up 80%, It's Time to Sell Bristol-Myers to Mead Johnson: It's time to walk on your own. Investors will have an option of exchanging some or all of their Bristol-Myers shares for shares in Mead Johnson for a slight discount |
IndustryWeek February 1, 2006 Jill Jusko |
Procurement: Heightened Visibility Spend analysis opens the door to successful sourcing strategies. |